TABLE 9.
Synthetic drug/s | Cellular target and mechanism of action | Effect on NET formation | References | |
---|---|---|---|---|
1 | Amoxicillin | n.d | Increased NET formation | Bystrzycka et al. (2016) |
2 | Amphotericin B | n.d | Decreased NET formation | Decker et al. (2018) |
3 | Azithromycin | n.d | Decreased NET formation | Bystrzycka et al. (2017) |
4 | Cefotaxime | n.d | No effect on NET formation | Manda-Handzlik et al. (2017) |
5 | Clarithromycin | n.d | Increased NET formation | Konstantinidis et al. (2016); Arampatzioglou et al. (2018) |
6 | Chloramphenicol | n.d | Decreased NET formation | Bystrzycka et al. (2017) |
7 | Clozapine | n.d | No effect on NET formation | Irizarry-Caro et al. (2018) |
8 | Enrofloxacin | Increased expression of PAD (peptidylarginine deiminase) 4 protein, increased presence of citrullinated H3 | Increased NET formation | Jerjomiceva et al. (2014) |
9 | Erythromycin | n.d | Decreased NET formation | Zhang et al. (2019) |
10 | 17-β-estradiol | n.d | Increased NET formation | Yasuda et al. (2019) |
11 | Gentamicin | n.d | Decreased NET formation | Manda-Handzlik et al. (2017) |
12 | Hydralazine | n.d | Increased NET formation | Irizarry-Caro et al. (2018) |
13 | Mannitol hypertonic saline | Suppresses NOX2-dependent NETosis is via neutrophil dehydration | Decreased NET formation | Nadesalingam et al. (2018) |
14 | Melatonin | n.d | Increased NET formation | Xu et al. (2019) |
15 | Memantine | Stimulates the production of MPO | Increased NET formation | Peng et al. (2020) |
16 | Metformin | Reduction of elastase, proteinase-3 and histones concentration | Decreased NET formation | Menegazzo et al. (2018) |
17 | Minocycline | n.d | No effect on NET formation | Irizarry-Caro et al. (2018) |
18 | Procainamide | n.d | Increased NET formation | Irizarry-Caro et al. (2018) |
19 | Voriconazole | n.d | Decreased NET formation | Decker et al. (2018) |
n.d.- not defined.